Operative Outcomes of Women Undergoing Coronary Artery Bypass Surgery in the US, 2011 to 2020.


Journal

JAMA surgery
ISSN: 2168-6262
Titre abrégé: JAMA Surg
Pays: United States
ID NLM: 101589553

Informations de publication

Date de publication:
01 05 2023
Historique:
pmc-release: 01 03 2024
medline: 12 5 2023
pubmed: 2 3 2023
entrez: 1 3 2023
Statut: ppublish

Résumé

It has been reported that women undergoing coronary artery bypass have higher mortality and morbidity compared with men but it is unclear if the difference has decreased over the last decade. To evaluate trends in outcomes of women undergoing coronary artery bypass in the US from 2011 to 2020. This retrospective cohort study at hospitals contributing to the Adult Cardiac Surgery Database of the Society of Thoracic Surgeons included 1 297 204 patients who underwent primary isolated coronary artery bypass from 2011 to 2020. Coronary artery bypass. The primary outcome was operative mortality. The secondary outcome was the composite of operative mortality and morbidity (including operative mortality, stroke, kidney failure, reoperation, deep sternal wound infection, prolonged mechanical ventilation, and prolonged hospital stay). The attributable risk (the association of female sex with coronary artery bypass grafting outcomes) for the primary and secondary outcomes was calculated. Between 2011 and 2020, 1 297 204 patients underwent primary isolated coronary artery bypass grafting with a mean age of 66.0 years, 317 716 of which were women (24.5%). Women had a higher unadjusted operative mortality (2.8%; 95% CI, 2.8-2.9 vs 1.7%; 95% CI, 1.7-1.7; P < .001) and overall unadjusted incidence of the composite of operative mortality and morbidity compared with men (22.9%; 95% CI, 22.7-23.0 vs 16.7%; 95% CI, 16.6-16.8; P < .001). The attributable risk of female sex for operative mortality varied from 1.28 in 2011 to 1.41 in 2020, with no significant change over the study period (P for trend = 0.38). The attributable risk for the composite of operative mortality and morbidity was 1.08 in both 2011 and 2020 with no significant change over the study period (P for trend = 0.71). Women remain at significantly higher risk for adverse outcomes following coronary artery bypass grafting and no significant improvement has been seen over the course of the last decade. Further investigation into the determinants of operative outcomes in women is urgently needed.

Identifiants

pubmed: 36857059
pii: 2802105
doi: 10.1001/jamasurg.2022.8156
pmc: PMC9979009
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

494-502

Commentaires et corrections

Type : CommentIn

Auteurs

Mario Gaudino (M)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

David Chadow (D)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Mohamed Rahouma (M)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Giovanni Jr Soletti (GJ)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Sigrid Sandner (S)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Roberto Perezgrovas-Olaria (R)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Katia Audisio (K)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Gianmarco Cancelli (G)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Brenden A Bratton (BA)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Stephen Fremes (S)

Schulich Heart Centre, Sunnybrook Health Science University of Toronto, Toronto, Ontario, Canada.

Paul Kurlansky (P)

Department of Surgery, Center for Innovation and Outcomes Research, Columbia University Medical Center, New York, New York.

Leonard Girardi (L)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York.

Robert H Habib (RH)

The Society of Thoracic Surgeons Research Center, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH